Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NMDA Enhancers in the Treatment of Schizophrenia: Sarcosine vs. D-Serine

NCT00491569 is registered in ClinicalTrials.gov with China Medical University Hospital as lead sponsor.

NCT NCT00491569
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00491569 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NMDA Enhancers in the Treatment of Schizophrenia: Sarcosine vs. D-Serine
Lead sponsor
China Medical University Hospital
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2005
Completion date
December 31, 2006
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

psychoses, psychotic disorders, schizophrenias, schizophrenic disorders